Bayno, Herminegildo .
HRN: 26-77-53 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/05/2025
CEFTRIAXONE 1G (VIAL)
04/06/2025
04/23/2025
IV
2g
OD
Pleural Effusion Secondary To Parapneumonic Process
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes